AAAAAA

   
Results: 1-8 |
Results: 8
Impact of high-dose chemotherapy on peripheral T-cell lymphomas
Authors: Rodriguez, J Munsell, M Yazji, S Hagemeister, FB Younes, A Andersson, B Giralt, S Gajewski, J de Lima, M Couriel, D Romaguera, J Cobanillas, FF Champlin, RE Khouri, IF
Citation: J. Rodriguez et al., Impact of high-dose chemotherapy on peripheral T-cell lymphomas, J CL ONCOL, 19(17), 2001, pp. 3766-3770
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
Authors: Gopal, R Ha, CS Tucker, SL Khouri, IF Giralt, SA Gajewski, JL Andersson, BS Cox, JD Champlin, RE
Citation: R. Gopal et al., Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity, CANCER, 92(7), 2001, pp. 1949-1958
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Authors: Khouri, IF Saliba, RM Giralt, SA Lee, MS Okoroji, GJ Hagemeister, FB Korbling, M Younes, A Ippoliti, C Gajewski, JL McLaughlin, P Anderlini, P Donato, ML Cabanillas, FF Champlin, RE
Citation: If. Khouri et al., Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, BLOOD, 98(13), 2001, pp. 3595-3599
Tacrolimus does not abrogate the increased risk of acute graft-versus-hostdisease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB I and HLA-DQB I
Authors: Przepiorka, D Saliba, R Cleary, K Fischer, H Tonai, R Fritsche, H Khouri, IF Folloder, J Ueno, NT Mehra, R Ippoliti, C Giralt, S Gajewski, J Donato, M Claxton, D Braunschweig, I van Besien, K Anderlini, P Andersson, BS Champlin, R
Citation: D. Przepiorka et al., Tacrolimus does not abrogate the increased risk of acute graft-versus-hostdisease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB I and HLA-DQB I, BIOL BLOOD, 6(2A), 2000, pp. 190-197
Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients
Authors: Romaguera, JE Khouri, IF Kantarjian, HM Hagemeister, FB Rodriguez, MA McLaughlin, P Sarris, AH Younes, A Rodriguez, J Cabanillas, F
Citation: Je. Romaguera et al., Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients, LEUK LYMPH, 39(1-2), 2000, pp. 77-85
Allogeneic haematopoietic transplantation for Richter's syndrome
Authors: Rodriguez, J Keating, MJ O'Brien, S Champlin, RE Khouri, IF
Citation: J. Rodriguez et al., Allogeneic haematopoietic transplantation for Richter's syndrome, BR J HAEM, 110(4), 2000, pp. 897-899
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy
Authors: Khouri, IF Lee, MS Romaguera, J Mirza, N Kantarjian, H Korbling, M Albitar, M Giralt, S Samuels, B Anderlini, P Rodriguez, J von Wolff, B Gajewski, J Cabanillas, F Champlin, R
Citation: If. Khouri et al., Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy, ANN ONCOL, 10(11), 1999, pp. 1293-1299
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma
Authors: Khouri, IF Romaguera, J Kantarjian, H Palmer, JL Pugh, WC Korbling, M Hagemeister, F Samuels, B Rodriguez, A Giralt, S Younes, A Przepiorka, D Claxton, D Cabanillas, F Champlin, R
Citation: If. Khouri et al., Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma, J CL ONCOL, 16(12), 1998, pp. 3803-3809
Risultati: 1-8 |